Cargando…
Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer
Advanced prostate cancer (PrCa) is treated with androgen deprivation therapy, and although there is usually a significant initial response, recurrence arises as castrate resistant prostate cancer (CRPC). New approaches are needed to treat this genetically heterogeneous, phenotypically plastic diseas...
Autores principales: | Pan, Hong, Jansson, Keith H., Beshiri, Michael L., Yin, JuanJuan, Fang, Lei, Agarwal, Supreet, Nguyen, Holly, Corey, Eva, Zhang, Ying, Liu, Jie, Fan, HuiTing, Lin, HongSheng, Kelly, Kathleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652772/ https://www.ncbi.nlm.nih.gov/pubmed/29100379 http://dx.doi.org/10.18632/oncotarget.20424 |
Ejemplares similares
-
Prostate organoids: emerging experimental tools for translational research
por: Beshiri, Michael, et al.
Publicado: (2023) -
EGR1 Regulates Angiogenic and Osteoclastogenic Factors in Prostate Cancer and Promotes Metastasis
por: Li, Lechen, et al.
Publicado: (2019) -
A Gamboge Case
por: Biegler, J. A.
Publicado: (1887) -
Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012) -
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer
por: Jansson, Keith H., et al.
Publicado: (2018)